Aporte a la rutina de la trinchera asistencial donde los conocimientos se funden con las demandas de los pacientes, sus necesidades y las esperanzas de permanecer en la gracia de la SALUD.
martes, 29 de junio de 2010
guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS).
GUIDELINE TITLE
British Committee for Standards in Haematology
GUIDELINE TITLE
UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS).
BIBLIOGRAPHIC SOURCE(S)
Bird J, Behrens J, Westin J, Turesson I, Drayson M, Beetham R, D'Sa S, Soutar R, Waage A, Gulbrandsen N, Gregersen H, Low E, Haemato-oncology Task Force of the British Committee for Standards in Haematology. UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS). Br J Haematol 2009 Oct;147(1):22-42. [70 references] PubMed
GUIDELINE STATUS
This is the current release of the guideline.
open here to see the full-text:
http://www.guideline.gov/summary/summary.aspx?ss=15&doc_id=15517&nbr=&string=
No hay comentarios:
Publicar un comentario